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Relatively little is known of the mode of action of erythromycin. This
antibiotic is widely used in the treatment of infectious diseases and has un
doubtedy prolonged the lives of thousands of people. It would seem ax
iomatic that more knowledge of the mode of action would serve as a
foundation for more effective clinical use.
Although Pittenger et al. (1) and Haight and Finland (2) had tested
some organic and inorganic compounds for reversal of the inhibitory action
of erythromycin, it seemed profitable to use a more informative method,
Such tests have usually been carried out in liquid media using a single con
centration of the compound in question and one level of the inhibitory sub
stance. It was felt that by the use of agar plates, seeded with a sensitive
organislU, a solution of the test compound could be introduced 00 a filter
paper disk. Through diffusion an infinite variety of concentrations of the
test substance would be present in concentric zones around the filter paper
disk. The antibiotic could be added either in the bacteriostatic threshold con
centration to the liquid seeded agar medium before pouring the plate, or
added on filter paper disks close to the test compound disks on the hardened
agar surface. After incubation the zones of growth or inhibition could be
interpreted in terms of reversal or potentiation of the inhibition of erythro
mycin and toxicity of the test compound.
Brown and Emerson (3) found that pantothenic acid, beta-alanine and
carnosine reversed the inhibitory action of erythromycin towards the gral;is
strain of Corynebacterium diphtheriae. No confirmation has been made to
date by other investigators. It would seem desirable not only to attempt to
confirm their work but also to look for a similar situation in other organisms.
It appeared that organisms in which such an effect would be most apparent
,vould be those which require either pantothenic acid or beta-alanine for
growth. In this category LactobaciJlus casei and L. arabillOJIIJ require pan
tothrnic acid for growth and numerous strains of yeast require either pan·
tothenic acid or beta-alanine. Since erythromycin is used in the treatment of
diseases caused by DiplofOatls. MlcrocOCCtLJ and StreptoCO(CIIJ, it seemed
pertinent to use those organisms to test for the reversal by pantothenic acid
or beta-alanine of the inhibition due to erythromycin. Finally, it seemed de
sirable to determine whether the resistance of highly resistant strains of Mi·
179

aococrtlJ pyogr:'ll/;,S vaL aUl'ellJ is due to high production of pantothenic acid.

Many organisms which are resistant to penicillin are resistant by virtue of
their production of penicillinase, an enzyme capable of destroying penicillin.
This enzyme has been found to be extracellular and intracellular in nor
mally resistant organisms and in organisms in which the resistance has de
veloped (4). As one of the possible mechanisms of resistance to
erythromycin, it seemed obvious that an attempt should be made to find
erythromycinase. Haight and Finland (2), using many strains of the highly
resistant gram-negative organisms, could find no extracellular erythromy
cinase. Since resistance in staphylococcal infections has become a serious
problem, it appeared of value to determine the presence or absence of intra
cellular or extracellular erythromycinase in the two highly resistant strains of
iY[icl'ococors pyogelleJ' vaL ourem available.
One possible mode of action of erythromycin would be its interference
with the functioning of one or more enzymes necessary to the growth or re
production or action of the sensitive organism. Stone et at. (5) recently re
ported that staphylococci which were highly resistant to erythromycin in
vitro were still sensitive when treated in vivo in mice. Since the pathogenicity
of the staphylococcus is closely associated with coagulase production, one
explanation for this phenomenon would be an inhibition of coagulase by
the antibiotic.
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REVIEW OF THE LITERATURE
Erythromycin has the formula C37HG1N013 with a structure approximat
ing that shown in Fig. 1 and a molecular weight of 734. It is a base with a pK
8.6. It is slightly soluble in water and more readily soluble in organic sol
vents. A pH of less than 4 or higher than 10 is highly destructive (6, 7).
Degradation studies have led to the identification of large fragments, includ
ing erythralosamine, C29H49NOg, and c1adenose, C SH 16 0.l (Fig. 1) (7), One
fraction of erythralosamine is desosamine, C S H l i N0 3 (Fig. 1) (7). A large
fragment, dihydroerythronolide, CZ1H4l0S, has been described (Fig. 1) (8).
Erythromycin appears to be a member of a group of antibiotics which in
cludes: albomycetin (C32H 54 N0 9, mol. wt" 596) (9), amaromycin (10),
angolamycin (C-J.9-51HS7-9l-N01S, mol. wt., 977-1005) (11), carbomy
cin (C41 H 6 ,N0 1G , mol. wt., 830) (12,13), carbomycin B (C.U-42H61-69
NOlo, moL wt., 814-828) (14), celesticetin (Cz4H3fJ-40NzOlh mol. wt.,
496-500) (15), erythromycin B (C 37 H l1 N0 J2 , mol. wt., 721) (16), griseo
mycin (17), leucomycin (CZ,H4ZN010' mol. wt., 540) (18), methamycin
(C25H43NOr, mol. wt., 470) (19), narbomycin (C28H-J.7NO .. , mol. wt.,
510) (20), antibiotic PA-105 (21), pikromycin (Cz5H43N07, mol. wt.,
477), (22), rhodomycin (23) and spiromycin (24).
In general the members of the erythromycin antibiotic group exhlbit
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a. erythromycin,
b. desosamine,
c. c1adenose,
tl. dihydroerythronolide,
e. erythralosamine (R is dihydroetyrhronolide
minus 2H; R' is dihydroeryrhronolide minus 2H,O).

Similar antibacterial and antiviral spectra. The resemblance of the spectra of
carbomycin (12), celesticetin (25), erythromycin B (26), griseomycin
(17), antibiotic PA-I05 (21) and spiromycin (24) to that of erythromycin
has been noted by other investigators. Organisms show Lng moderate to high
sensitivity to erythromycin include the following genera: BMil/tls, BruceLltl..
Clostridium, COfJllebacterillm, DiplococctlJ, H emophiflls, Micrococcus, My
cobacterium, Neisseria. RickettJia. Streptococcus, Vibrio.. lymphogranuloma
virus and meningopoeumonitis virus. In general the gram-negative organ181

isms, E5cherichitl. Pro/elts. Pselldomollas. Salmol/elltl and Shigella show high
resistance. There are variations in the degree of effectiveness of the different
members of this antibiotic family. Carbomycin, for example, is usually less
effective than erythromycin. There are some marked differences. Amaromy
cin, for example, inhibits Bmcelttl tlbOrllfs with 1.56 mcg/ml (10) while
erythromycin does not inhibit the organism with 1000 111cg/ml (17) even
though it is quite active against other members of the genus (6).
Cross-resistance has been demonstrated between erythromycin and erythro
mycin B (27), carbomycin (28), celesticetin (25), griseomycin (17), anti
biotic PA-I05 (n), and spiromycin (24). Cross-resistance evidence
suggests that leucomycin is closely related to carbomycin and somewhat less
closely related to erythromycin (29).
The chemical structure desosamine has been demonstrated in erythromy
Cill (7), erythromycin B (16), pikromycin (23) and narbomycin (20).
Carbomycin and carbomycin B contain the very similar desoxydimethyl
amino sugar. mycaminose (14). In rhodomycin the order in which the radi
cals are attached to the desosamine ring has been changed (23). One of the
radicals attached to the ring structure in desosamine is a dimethyl amine. It is
interesting to note that albomycin (9), angoJamycin (11), carbomycin (12),
carbomycin B (14), erythromycin (7), erythromycin B (16), leucomycin
(18), methamycin (19), narbomycin (20) and pikromycin (22) all have
but a single nitrogen atom.
The literature on other members of the erythromycin antibiotic family!
reviewed here, indicates no mode of action.
The effect of various inorganic and organic substances on the bacterio
static action of erythromycin has been investigated. Pittenger et al. (1);
working with Micrococclis pyogene.r var. tl1lreus in vitro, found that various
concentrations of Cl-, NO,:-, SO~-, Na+, K+, Mg++, Ca++, Mn++,
Cu++, Co+ +, Fe++, Zn + +, Na-thioglycollate, cysteine-Hel, acetate, fuma
rate, alpha-glutarate, malate, oxalactate, pyruvate, succinate, citrate and vita
min mixtures (riboflavin, thiamin, biotin, niacin, p-aminobenzoic acid, calci
um panthothenate, pyridoxine, pyridoxal, pyridoxamine and folic acid) had
neither appreciable potentiation or reversal of the bacteriostatic ability of
erythromycin. Haight and Finland (2) found that various concentrations
of NaCl, dextrose, Na-thioglycollate, cysteine·HCl, semicarbozide, urea,
glutamic acid, p-aminobenzoic acid and pteroylglutamic acid had no signif
icant effect on the in vitro inhibition of Bacillus cereus no. 5 by erythromycin.
They also reported that various concentrations of the sodium salts of citric,
pyruvic, acetic, lactic, fumaric and succinic acids and the enzyme penicil
linase had no effect on the inhibition of St-rep/ococCtfJ no. 98. Hun1an sera
at various levels had no effect on the antibiotic's inhibition of Sarcina It/Jea.
Brown and Emerson (3) reported that 500 mcg/Il1l beta-alanine or calcium
pantothenate, equivalent to 200 mcg/ml beta-alanine, permitted growth of
182

...

COlpll:!:
centmti,
beta·ah
concent
Hai,g
inhibitc
t/ll/:,(/, r'
et al. (!
coccus I
also no
of eryt}
Pitteng
the salt
was du,
Hai t
oxygen
mycm,
/OCOCC1l
or an el
Resi:
tenger
resistar
ence 01
slightl]
less raF
conditt
erythrc
of 1\1.
carbon
Hat!
are nal
metho'
bade!'
StltmOi
erythr<
amour:
destw
P1'olet,
a soJul
Ob'
this al
withol
being

01/(1.1, Sci/II/ollelfa and Shigella show high
he degree of effectiveness of the different
Carbomycin, for example, is usually less
are some (1):lrked differences. Amarol11y
abor/llf with 1.56 mcg/l11[ (10) while
organism with 1000 mcg/ml (17) even
r members of the genus (6).
trated between erythromycin and erythro
elesticetin (25), griseornycin (17), anti.
lycin (2-1). Cross- resistance evidence
elated to carbomycin and somewhat less

).
e has been demonstrated in erythromy
'kromycin (23) and narbomycin (20).
ntain the very similar desoxydil11ethyl
rhodomycin the order in which the radi
ring has been changed (23). One of the
~ in desosamine is a dimethyl amine. Tt is
), angoIamycin (11), carbomycin (12),
(7), erythromycin B (16), leucomycill
in (20) and pikromycin (22) all have
of the erythromycin antibiotic family,
action.

d organic substances on the bacterio
1 investigated. Pittenger et a1. (1),
var. (/!/reIlJ in vitro. found that various
-, Na+, K+, Mg++, Ca++, Mn++,
ioglycollate, cysteine-HCI, acetate, flUna
ate, pyruvate, succinate, citrate and vita
iotin, niacin, p-aminobenwic acid, Gllci
xal, pyridoxamine and folic acid) had
reversal of the bacteriostatic ability of
(2) found that various concentrations
te, cysteine-HCI, semicarbozide, urea,
nd pteroylglutamic acid had no signif
of Baci!!!I.f cerell5 no. 5 by erythromycin.
entcations of the sodium salts of citric.
succinic acids and the enzyme penicd
n of Slrep/owceus no. 98. Human sera
antibiotic's inhibition of St/l'cincl ltltea.
at 500 mcg/ml beta-alanine or calcium
/ml beta-alanine, permitted growth of

82

,

I

COI')'l7ebaderilllll diphlhe1'icle in 70 times the original minimal inhibitory con·
centration of erythromycin. L·carnosine, equivalent to 100·400 l11cg/ml of
beta-alanine, reversed the inhibition of up to 30 times the minimal inhibitory
concentration of the antibiotic.
Haight and Finland (2) found a 530 and 800·fo[d increase of the in vitro .
inhibitory activity of erythromycin against Streptococct/s no. 98 and Sm'cilla
INtea. respectively, when the pH was increased from 5.6 to 8.5. Pittenger
et ai. (1) found a 30- fold increase in the bacteriostatic action against hlicro
coatis pyogenes var. t/l/1'n/J with the increase of pH from 6.5 to 8.5. They
also noted that an apparent potentiating effect of phosphates on the activity
of erythromycin was actually due to the effect of the buffering action on pH.
Pittenger et al. (1) suggested that the free base had much more activity than
the salt of the antibiotic and that the increase of activity as the pH increased
was due to release 0 f the free base.
Haight and Finland (2) found that a change in the pH by replacing the
oxygen with carbon dioxide did not affect the bacteriostatic action of erythro
mycin against Streptocou!fJ no. 98, StreptococotJ C203, S<lrCilU/ lutecl: Strep
tOCOCClif viridt/llJ) DiplococntJ pnell1170niae type III, S/aph)'locoCl'ttJ no. 195
or an enterococcus.
Resistance has been developed in sensitive strains in the laboratory. Pit
tenger et ai. (1) found that J'rlicl'omcCfts pyogel!eJ var. o,,/·ret/.f increased its
resistance to erythromycin about 300-fold in 25 serial transfers in the pres
ence of the antibiotic. The development of resistance to erythromycin was
slightly less rapid than the development of resistance to penicillin and much
Jess rapid than the development of resistance to streptomycin under the same
conditions. No organism which had become nutritionally dependent on
erythromycin was found. Hsie and Kotz (30), however, developed a strain
of M. pJogenes var. aflrellJ which had become nutritionally dependent on
carbomycin.
Haight and Finland (2) attempted to determine whether species which
are naturaJly resistant to erythromycin produce erythromycinase. Using the
method of Gots (31) numerous strains of Pseudomonas cleruginoJtI, Aero
bacter aerogenes: Klebsiella pneumoniae, E.rcheriehici coli, Pwtetts vulgaris,
Salmonella and Shige!!a were checked for the production of an extracellular
erythromycinase which would destroy erythromycin which was present in an
amount just inhibitory to the test organism, Sarcina lutea. No evidence of
destruction of the antibiotic was found. By a second method, suspensions of
Proteus llUlgMis and Escherichia coli organisms had no destructive effect on
a solution of erythromycin over a 72-hour period.
Obviously. there are present in nature mechanisms for the destruction of
this antibiotic. The erythromycin content of pLasma in vivo drops rapidly
without a corresponding amount being excreted in the urine or otherwise
being accounted for (2). One scrap of evidence of its metabolism has been
183

found. Des-N-methyl erythromycin has been isolated from the bile of dogs
(32).
Stone et al. (5) found that coagulase-positive strains of i\tficrococctIJ
pyogel1es var. alJretrs which had been isolated from human cases showed
large variation in in-vitro sensitivity but showed smalJ variation in in-vivo
sensitivity to erythromycin. Inhibition in vitro was caused by 0.195 mcg/ml
erythromycin for strain no. 3055A, 10,000 mcg/ml, for strain no. 3066A,
and 5,000 mcg/ml, for strain no. 3072A. In 20 to 25 g Swiss mice, the ef
fective dose of erythromycin 50 per cent of the time was 18 mcg for strain
no. 3055A, 22 mcg for strain 00. 3066A and 116 mcg for strain no. 3072A.
Of significance, in interpretation of this work, is the widely accepted belief
that coagulase production is the best indication of pathogenicity in strains of
jltI. pyogenes VaL tIt/rells (33). Boniece et al. (34) found that erythromycin
was effective in reducing the coagulase activity of numerous strains of M.
pyogenes var. atrret/J.
In one of the few papers on the effect of erythromycin on enzymes, Ja
cobson and Ayevedo (35) reported that erythromycin did not inhibit fll
merase, lipase, cholinesterase and thiaminase from animal sources or the
fermentation of alcohol by yeast.

MA TERIALS AND METHODS

Materials
ORGANISMS:
Bacilllis Sf/btllls, spore sllspension, strain X12.1. R. C. Pittenger
COfJlleb4eterill1JJ diphlhe,.iae, strain X166, R. C. Pittenger. slrain Toronto. McClain
Diplococc,,-, pTiellmoui"e. strain type 1, Park
UCiobacillus c({sei, no. 7469. American Type Culture Collection
MicrococCl/s !,jogenes vae. "",euf; strain no. 3055. strain no 3066, strain no. 3067,
strain no. 3074. all from Boniere
P"JleIlS ,'",/garis. strain no. 9484. American Type Culture Collection
Pseudomol/as (/erugillosa, slrain X239. R. C. Pittenger
SlrepIOCOC(JIS p)'o,~efleJ. C203, strain no. 8868. American Type Culture Collection
SdCC!JIlY07l1Jces cere"i.. iae; "Gebriider Marer:' strain no. 7752, "Old Process," Slrain
no 7753, "Fleischmann's Baker's," strain no. 7754, A'nerican Type Culture
Collection
MEDIA:

Brain heart infusion (Difco) used with COf)'i1ebtJclelll/liI
Hydroly:<erl caselll Inedium (>6) used "ith i\11CJ'OCOCCII.'
Mycin assa}' ager (Diko) used with B,1/I1I1I" sl/blllis
Tryplose- (Difro), l per cent, in nutrient broth (Difm) used with Cor)'llebaClculI1II
Pantothenic acid assay mediul11 (Difco) used with Lactobacilllls
Seed agar (Balti.lllore Biological Laboralories) used with Mlcrococcl/s. Prolell, and
PseudomoJ/(/J"

Tryptose medium (37) used with Dlploco((uj and StreplOfOCfI/S
YI:ast synlhetic medium (38. 39) used with yeast
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INSTRUMENTS:

Laboratory Model G. Bedcll1an pH l\1eter
Junior Speetrophutometer, Model 6A, Coleman Instruments, Inc.
OTHER MATERIALS:

II

Alumina A-,03, Aluminum Company of America
Discs of very pure, highly absorbenr paper for the assay of penicillin and other anll
bacterial substances, i·in (12.7 mm) dialfi, No. 740-E, Carl Schleicher and Schuell
Erythromycin standard solution. 100 mcg/In!' One hundred mg 'Ilotycin' (erythro·
lfiycin, Lilly), lot no. 652282. was dissolved in 100 ml 1 per cent sndium and
potassium phosphate solution adJnsted to a pH ot 7.0 (Hartman-Leddon Co.)
and filtered through a SeiTZ tilter. So)ntion was made nl' fresh at ]east once a
month and stored in a refrigerator unlll used.
"Tes-Tape," a paper impregnated wiTh glucose oxidase and horse·radish peroxi
dase, Eli Lilly Company

Screening of CompoundJ to Determille Reversal or Polenlitllioll of Arlion of
Erylhromycin
Method of Screening. Work was begun using seeded agar plates to which
erythromycin was added on a centrally located paper disk. Solutions of com·
pounds to be tested were added to paper disks which had been placed on the
agar. Part of the disk would cover agar in which the antibiotic would diffuse
from the erythromycin disk and would be expected to inhibit growth. Part
of the disk would cover agar where no inhibition would be expected to occur.
It was decided that seeded plates, in which a bacteriostatic threshold level
of erythromycin was present, would constitute a sensitive means of demon
strating any reversal action that a compound might have. In this event the
disk to which an active compound had been added would be surcounded by
a circular zone or a halo in which growth of the test organism took place. The
diameter of the zone would be related to diffusability of the compound as
well as to its inherent activity.
MirrococclIJ pyogeneJ vat. aUl'etlJ no. 3055, a strain sensitive to several
antibiotics, and spores of Barillus .wblilis were used for these tests. Synthetic
media were tried first and found unsatisfactory, Seed agar (BBL) was used
with M. pyogenes and mycin agar (Difco) was used with B. subtiIi;. Ten
ml of heated liquid agar was poured into a Petri dish. After the agar base
had hardened, 5 ml additional liquid agar containing 0.5 ml of a 1/100
dilution of either organism and, when indicated, containing 0.5 ml of the
appropriate concentration of erythromycin, were layered in on top. When
M. pyogenes was used, 50 mcg of the antibiotic was either incorporated in
the seeded agar or added to the paper disk. When B. subtilis was used, 10 mcg
of the antibiotic was used. The antibiotic was added to the paper disk in 0.05
m[ quantities; solutions of test compounds were added in 0.07 ml quantities.
To prevent absorption of moisture from the medium by the paper disks,
solutions were added to the disks immediately after they had been placed on
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the agar. Plates were incubated at 37°C. for 24 hours and then examined for
growth.
Compounds Screened. A large number of compounds were screened for
effect on the inhibitory action of erythromycin against Microcorws pyogenes
vaL dUI'eIlS and the spores of Bc/cillus slIb/.i1iJ, using both techniques. Com
pounds and their per cent concentration in solution were as follows:
amino acids: DL-alpha.alanine, 1 and 10; beta-alanint-, O.l and 10; L.arginine, 1;
DL-aspartic acid, 1 and 2; hydrolyzed casein. (vitamin·[rt-e). 10: DL-citrulline, I:
creatine. 1: L·cysteine·HCI, 1 and 10: ethionine. 1; L-gl utamic acid, 1 and 2:
L·histidine·HC!. I and 5; DL-isoleucine, 2; L-Ieucine-HCI, 1: DL-Iysine-HCI. 1;
DL-1l1elhionine, I: norleucine. 1; DL·pht-nylaLtoine. 1; L-proline, 1; DL-serine,
1: DL-threonine. 1: DL-tryptophan. 1; DL-valine. 2
purines: adenine sulfate, 1; guanine-HCI, 0.7: uracil. 1: xanthin.e, 1 (All purines
were brought into sollittOn with NaOH.)
organic acids: citric acid, 1 and 10; oxalic aCid, 1 and 10
vitamins: acetyl choline·HC!' 10: ascorbic acid. 1; bela-alanine. 0.1 and 10; biotin,
O.OOO,O·i, Ca-pantothenate, 0.1 and 1; inositol, 0.1; niacin, 0.06: p·aminobe07oic
acid, I; pimelic acid. 0.025; pyridoxine. 0.12, thiamine-HC!. 0.1; yeast extract. 10
carbohydrales: dextrost-, J 0: lactose, 10: levulose, 10: D-I\lallose, 1: mannost-, I;
mannitol, 10; ratllnose. 10, rhamno"e. 2. ribose. 1; ,ucrose. 1 and 10: xylose, 10
miscellaneous organic compuuods: adeoylic acid, 1: L-asparagine, 1 and 10; beef ex
tract, 10: betaIne, I; cr<:atinine, 1; desosanllne, 10: D-glucosamine. 1: glutathio
nint-, 1; glyC<:IOI. 10; mercaptoethyJ amine; 10: mucio. 5; Na-thioglycollate, 1;
tetla sodium salt of ethylene diamint- tetra acetic acid, 9.4
inorgaoic compounds: FeSO.. 7H,O, 0.1 and 10: KCJ, 0.1; ZnSOdH,O, 0.1: 1'150"
0.1; HJBO" 0.1; NaH,PO, and Na,HPO, (pH 7.0), 10

Hydrogen [on fOilcen/.rfl/.;on. The pH was determined for all samples
screened which had not been previously discarded.
Since some of the compounds which reversed erythromycin were fOund to
have pH's of 4.0 or less, the pH's of the solutions of seven of these com
pounds, adenylic acid, ascorbic acid, L-aspartic acid, L-cysteine-HeI, L-glu
tamic acid, glutathione and L-histidine-HCI, were brought up to the range
of 6.0 to 7.0. Solutions of these neutralized compounds were added to paper
disks on seeded plates containing a bacteriostatic amount of the antibiotic
and checked for reversal of the action of the antibiotic.
L.Cy.rleiJ7e-Hydrorhloride. This compound was tested for reaction with
erythromycin under mildly acid conditions. A 0.2 per cent L-cysteine-HCI
solution was made in erythromycin standard solution and the pH adjusted to
5.2. As a control, erythromycin standard solution was adjusted to a pH of 5.2.
The cysteine-erythromycin and control solutions were heated in a 56°C.
water bath for 1 hour. fifteen ml of each solution were filtered through a
Seitz filter and compared, using paper disk assay techniques with both test
organisms. The diameters of the zones of inhibition were measured and com
pared as an indication of comparative potency. The remainder of the cysteine
erythromycin and control solutions were stored in a refrigerator at 6°C. for
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about 72 hours. The solutions were then filtered and comparative potencies
again determined.
Organic and Inorganic acidJ. In view of the data which showed that com
pounds which reverse the action of erythromycin were acidic, additional acid
substances were tested in the same manner as the original screening. Sub
stances tested were alanine 2 per cent and HCl 1 per cent, glycine 2 per cent
and HCl 1 per cent, HCl 1 per cent, lactic acid 1 per cent, malic acid 1 per
cent, H~SO~ 1 per cent and tartaric acid 1 per cent.
Rev;!Jal. Finally, chemicals with the ability to reverse the action of erythro
mycin, including aciclic substances, were checked for revival of organisms
which had been inhibited by erythromycin. Agar plates seeded with either test
organism and containing bacteriostatic concentrations of erythromycin were
incubated at 3
for 24 hours. Solutions of test compounds were added to
paper disks on the surface of the agar. The plates were incubated an addi
tional 4R hours and then examined for revival of organisms.

rc.

Investigation of the Rewl'Sal by Calcit/m Pantothenafe and Beta-Alanille
of the Inhibitory Effects of Erythl'Omycin 011 Se1Jerai Spec;eJ 0/ Bacter;a
Laclobacill/ls c,He;, L. (,lSei was used to determine if Ca-pantothenate and
beta-alanine have the ability to reverse the inhibition caused by erythromycin.
The procedure followed was that of the Difco Manual (40). Amounts of Ca
pantothenate added to the tubes were equivalent to 0, 0.02, 0.2, 2 ancl 20
mcg/ml of the final voltHne. four tubes containing each level of Ca·panto
thenate received 0, 0.04, 0.2 and 1 meg erythromycin per ml of the final
volume, respectively (Tahle 1). Distilled water was added to bring the
volume to 5 mL Five ml pantothenic acid assay medium was added. The cuI·
ture tubes were sterilized by autoclaving and then inoculated with a suspen·
sion of washed L. cClse;. The cultures were incubated at 37°C. for 72 hours.
The pH was determined for each culture. An interpretation was made on
the basis of pH as an indication of growth and acid production. This test
was repeated. Subsequently, a test was set up in which all tubes recei I'ed
0.2 mcg/ml Ca-pantothenate. Amounts of beta-alanine added to tubes were
0, 0.2, 2, 20 and 200 mgc/lnl of the final volume. Four tubes containing
each level of beta-alanine received 0, 0.2, 2, and 20 meg erythromycin per
ml of the final volume, respectively (Table 2).
Saccharomyces cerevis;ae. Three strains of S. cere1J;riae. "Old Process,"
"Fleischmann's Baker's" and "Gebriider Mayer," were checked for their
requirements of Ca-pantothenate. Using the synthetic medium of Williams
et a!. (38, 39) "Gebruder Mayer" gave the greatest response to the addition
of Ca-pantothenate to the medium. A test was set up with all tubes in du
plicate. Amounts of Ca-pantothenate added to the tubes were equivalent to
0,0.005,0.01,0.02,0.03,0.04 and 0.05 mcg/ml of the final volume. Eight
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tubes containing each level of Ca-pantothenate received 0, I, 10 and 100
mcg erythromycin per ml of the final volume for each pair, respectively
(Table 3). After inoculabion, tests were incubated at room temperature for
5 days. Readings of optical density were made at a wave length of 550
lambdas with a spectrophotometer. Subsequently, anot.her test was run in
which amounts of beta·alanine added to the tubes were equivalent to 0, 0.2,
0.4, 0.6, 0.8 and 1 mcg/ml of the final volume. Eight tubes containing each
level of beta·alanine received 0, 1, 10 and 100 mcg erythromycin per ml of
the final volume [or each pair, respectively (Table 4).
j\1icrococrus pyogenes var. atlreus. M. pyogenes var. aw'eus, strains no.
3055 and no. 3067, were investigated using hydrolyzed casein medium (36).
Amounts of Ca'pantothenate added to the tubes were equivalent to 0, 0.1, 1
and 10 mcg/ml of the final volume; amounts of beta.alanine, were equivalent
to 0, 10, 100 and 1000 mcg/ml. for each strain a set of four tubes at each
level of Ca-pantothenate or beta-alanine received 0, 0.1, 0.2, 0.5, 1 and 2
mcg erythromycin per mL of the final volume, respectively (Table 5). After
inoculation, cultures were incubated at 37°C. for 5 days. Growth was de
termined by a visual estimate of the turbidity. Very heavy growth was given
a value of 4; heavy growth, 3; moderate growth, 2; slight growth, 1; and no
growth, O.
Streptocot't't/s pyogenes and DiP/ococctl.!' pnelltl7or/ide. S. pyogeneJ C-203
and D. pneumonie/e Park type 1 were investigated using tryptose medium
(37). Amounts of Ca-pantothenate added to the tubes were equivalent to
0, 0.1, 1 and 10 mcg/ml of the final volume; amounts of beta-alanine, were
equivalent to 0, 10, 100 and 1000 mcg/ml. For each organism a set of four
tubes containing each Level of Ca-pantothenate or beta-alanine received 0,
0.005, 0.01, 0.02 and 0.04 mcg erythromycin per ml of the final volume,
respectively (Table 6). After inoculation, cultures were incubated at 37°C.
for 4 days. Growth was determined by a visual estimate of the turbidity.
CO''J'l7ebaderium diphtheriae. C. diphtheriae strains X-166 and Toronto
were investigated using a medium of 1 per cent Tryptose (Difco) added to
nutrient broth. Amounts of Ca-pantothenate added to the tubes were equiv
alent to. 0, 0.1, 1 and 10 mcg/ml of the hnal volume; amounts of beta-alanine,
were equivalent to 0, 10, 100 and 1000 mcg/ml. For each strain four tubes
containing each level of Ca-pantothenate or beta-alaniue received a, 0.004,
0.0008, 0.016 and 0.032 mcg erythromycin per ml of the final volume, re
spectively (Table 7). It was necessary to use a large inoculum to get satis
factory growth. One drop of undiluted 5-day culture was used. After
inoculation, the cultures were incubated at 37°C. for 9 days. After vigorous
shaking, the growth was determined by a visual estimate of turbidity.

Pantothenic Acid P.roduction by Resistant SUe/im of Micrococcus pyogenes
val'. aUfeus. Two resistant strains of lV{. pyogenes var. at<reus, no. 3066 and
no. 3074, and sensitive strain no. 3055 were grown in hydroLyzed casein
188

medium'
oculation
quat of (
To each <
1 g myla
pH was
usingLa,
j;

Gots' .
(4), Pro
crococC/!J
lar eryth
seeded w
and whi(
with the
37°C. fo
the agar.

Breakt
Resistant
were use,
mycJl1ase
the prese
5 ml hyd
medium
with resi
erythrom
tubes. A
biotic be
erythrom
bation at
tubes. TI
from 1:;
strain no
of growt

Solve);
and Chal
grinding
ment of.
satisfact<
Parker (

Itothen<lte recei ved 0, 1, 10 and 100
l1 \'olume for each pair, respec.tively
re incubated at room temperature for
i\'ere made at a wave length of 550
bse<jllentJy, another test was run in
o the tubes were equivalent to 0, 0.2;
volume. Eight tubes containing each
<lnd 100 mcg erythromycin per ml of
ively (Table 4).
ftt pJogenes vae. atireus, strains no.
ing hrdroJyzed casein medium (36).
) the tubes were equivalent to 0, 0.1, 1
BOunts of beta-alanine, were e<juivalent
each strain a set of four tubes at each
'ne recclved 0, 0.1, 0.2, 0.5, 1 and 2
'ollllne, respectively (Table 5). After
t 37°e. for 5 days. Growth was de
rbidity. Vtry heavy growth was given
(; growth, 2; slight growth, 1; and no

OCCtJ.I' plle/lflZoniae. S. pyogenes C·203
investigated using tryptose medium
dded to the tubes were equivalent to
'olume; amounts of beta-alanine, were
rg/ml. For each organism a set of four
tothelute or beta-alanine received 0,
romycin per ml of the final volume,
ion, cultures were incubated at 37 0e.
a visual estimate of the turbidity.
'ph/heriele strains X-166 and Toronto
1 per cent Tryptose (Difco) added to
henate added to the tubes were equiv
final volume; amounts of beta-alanine,
mcg/ml. For each strain four tubes
. te or beta-alanine received 0, 0.004,
nycin per ml of the final volume, re
to use a large inoculum to get satis
uted 5-day culture was used. After
at 37°e. for 9 days. After vigorous
a visual estimate of turbidity.
irtant S/rllins of MicrococCI/S pyogenes
. PJogeneJ var. aurellS, no. 3066 and
~5 were grown in hydrolyzed casein

B

1
I
I
I

'I
I

'r

I

1
~

t
I

medium without the presence of pantothentic acid and beta-alanine. After in
oculation, the cultures were incubated at 37°e. for 24 hours. A 10 ml ali
<juot of each culture was autodaved at 15 lb. steam pressure for 15 minutes.
To each culture was added 10 ml4 per cent acetic acid, 2 ml Nil NaOH and
1 g mylase. The tubes were placed in a 50°e. water bath for 24 hours. The'
pH was brought to 7.0. These salnples were assayed for pantothenic acid
llSlOg Lac/obc/cillIJJ celse; in the manner earlier described.

/mJ estiga/ioll of the Presem'e of /1l/fCice/lti/ar 01' Ex/r4celltt/ar
Erylhl'omycil1ase
GOls' Method, Ex/racelltllclr Ery/hromyciI14se. Using the method of Gots
(4), ProteI'S mt!gllris. Pseudomonas aeruginosa and resistant strains of l'vei
crococCt/s pyogenes vae. aureus were checked for the production of extracellu
lar erythromycinase. Seed agar (BBl) plates were prepared which were
seeded with sensitive strains M. pyogenes vae. clttreus, no. 3055 and no. 3067
and which contained 1.4 mcg erythromycin per m!. The plates were streaked
WIth the above mentioned resistant organisms. The plates were incubated at
37°e. for 24 hours and examined for the growth of the seeded organisms in
the agar.
Breakdown of E1'Ylh1'omycill in Sollllion by EXlfacell"lar Erythromycin4se.
ReSIstant strains of Mic'rococclls pyogeneJ var. aUI'ellS, no. 3066 and no. 3074
were used in a second check for the production of an extracellular erythro:
myclllase. It had been previously determined that these strains could b"row in
t.he presence of 200 meg erythromycin per m!. Cellophane tubes containing
) mJ hydrolyzed casem medium (36) were immersed in 25 ml of the same
medium in 40 mm diam culture tubes. The dialyzing tubes were inoculated
with resistant strains no. 3066 and no. 3074, respectively, and 100 mcg
erythromycl,n per ml was added to the medium surrounding the dialyzing
tubes. A thud tube was jnoculated with sensitive strain no. 3055, no anti
biotic being added to the medium. A fourth tube was prepared in which
erythromYCin was added but no inoculation was made. After 72 hours incu
bation at 37~e.,. dilutions were made of the media outside of the dialyzing
tubes. The ddutlOns were made in hydrolyzed casein medium in 2-fold steps
from 1:2 to 1 :64. The diluted medium was then inoculated with sensitive
strain no. 3055 and incubated at 37°e. for 2 days. The presence or absence
of growth in the dilutions was noted.
Solllen/Treatment of Cells 10 Release Illlt'acellttlar Er)'/hromycin. Abraham
and ~hain (41) originally found penicilJjnase as an intracellular enzyme by
grInding up cells of EJChericbia coli, Kirby et al. (42) found that the treat
ment of MiCfOCOCClIs cells by fat-removing solvents, acetone and ether, was a
satisfactory means of making intracellular penicillinase a vai/able. Gilson and
Parker (43) found that by using the solvents at temperatures of - 20°e.
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they had less inactivation of the enzyme. Adapting the method of Gilson and
Parker to the facilities available, resistant strains, no. 3066 and no. 3074, of
/Y!icrOCO((!15 pyogenes var. allreJIS were checked for the production of
erythromycinase.
The entire surface of plates of seed agar (BBL) was inocuhlted with a
suspension of the resistant i\tL pyogmes strains. Two plates were inoculated
with each strain. After 24 hour incubation at 37°e., 3 ml sterile saline solu
tion were added to each plate. The organisms were suspended in saline solu
tion. About 5 ml of suspension of each strain were harvested and added to a
centrifuge bottle. Each centrifuge bottle was placed in a beaker of alcohol
which had been cooled at -20°e. Twenty-eight ml of acetone, cooled to
-20°e., were gradually added with shaking. The suspension in the centri
fuge bottle was maintained within the range of -1 O°e. to - 20°e. After 75
minutes with frequent shaking, the acetone was removed with suction. An
addition,l! 25 ml of -20°C. acteone was added to the residue and the sus
pension maintained at -100e. to -20°e. with frequent shaking for 75
minutes. The acetone was again removed with vacuum. This time, 25 m: of
-20°e. ether were added to the residue and the suspension maintained at
-10°e. to -20°e. with frequent shaking for 75 minutes. The ether was re
moved with suction. The residue in the centrifuge bottle was dried by
evacuation to a pressure of below 100 microns Hg for 1 hour.
Erythromycin was added to hydrolyzed casein medium at dilutions from
1 meg to 200 mcg per ml of final volume. One series of tubes served as con
trols, a second series received a suspension of no. 3066 treated cells; a third
series received a suspension of no. 3074 treated cells. All tubes were inoc
ulated with a suspension of the sensitive no. 3055 strain. excepting sterility
controls. Since sterility controls on inoculation indicated that viable M;cro
COCOIS cell,r were present in the residues, another plan was necessary to dem
onstrate the presence or absence of erythromycin.
An erythromycin standard solution was brought in contact with the de
fatted cells, sterilized by filtration, and checked for destruction of the anti
biotic. A tube containing 3 ml of erythromycin standard solution, 1000 meg
of the antibiotic per ml, received 1.7 mg of defatted no. 3066 cells; a second
tube received 4.1 mg of defatted no. 3074 cells; a third tube received no
cells and acted as a control. All tubes were left at room temperature for 48
hours. Twelve ml distilled water were added to each tube and the contents
then filtered through a Seitz filter. Dilutions of the filterates added to hy
drolyzed casein medium were equivalent to 0,0.10,0.39,1.56,6.25,25 and
100 meg of erythromycin originally present per rol of final volume. All tubes
were inoculated with the sensitive strain no. 3055 of iV[. pyogenes var. ttureus.
After incubation at 37°e. for 4 days, the tubes were examined for growth.

Physical De,rlt'ucliol1 of Cell Wall to Release Intracelllllar Erythromy
cjut/se. According to Hugo (44) and McIlwain (4:;), a very satisfactory
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method of preparing cell-free enzymes is by the physical rupturing of the
cell wall with fine abrasives. Resistant strains no. 3066 and no. 3074 of M;
crOWCCNS pyogenes var. maetl.. and the resistant organisms Protetls 1Jttlgtlris
and Pseudomol1t!S aeFugil70sa were treated in this manner to determine the
presence of intracellular erythromycinase.
The entire surfaces of two plates of seed agar (BEL) were inoculated with
each strain of organism used in this experiment. After 24 hour incubation at
37°e.. 4 ml sterile saline solution were added to each plate and the organ
isms therein suspended. About 8 ml of each strain were harvested aud placed
in a centrifuge tube. The cells were centrifuged down in an angle head centri
fuge and had a final volume of about V4 ml. The residue was transferred to a
cooled sterile mortar. Six-tenths g of Alumina A-303 were added. The cells
were ground with a pestle for 1 minute following the procedure described by
McIlwain (4»). The ground cells were resuspended in 2 ml sterile saline
solution and 1 ml erythromycin standard solution. The suspensions were re
frigerated at 6°e. for 24 hours and then left at room temperature for 24
hours. Next they were diluted with 27 1111 distilled water each and were
sterilized by filtration through Seitz filters. The filtrates were added to hy
drolyzed casein medium in amounts eguivalent to 0, 0.1, 0.4, 1. 2, 3.7 and 11
mcg of erythromycin originally present per ml of final volume. All tubes
were inoculated with the sensitive strain no. 3055 of M. p)'ogenes var. eU/rellS.
After incubation at 37°e. for 3 days, growt.h was determined by visual in
spection.

The Effect of Erythrom)'cin 011 the Actioll of Cot/gulase timl Othe1' Enzymes
Coagulase tests were carried out in a manner similar to that described in
the Difco Manual (46). Plasma was prepared from rabbit blood to which
1 per cent Na-oxalate was added. Dilutions of erythromycin were made in
distilled water with erythromycin standard solution. Derivatives of erythro
mycin were dissolved or suspended in distilled water. Micrococcus pyogenes
var. rlf.lreus was grown in Brain Heart Infusion (Difco) at 37°e. for 24
hours. Suspensions of the organisms were staudardized at 42.5 per cent light
transmission at a wave length of 550 lambdas in a spectrophotometer. Five
tenths ml plasma were measured into an 11 mm by 65 mm culture tube; 0.1
ml erythromycin solution, derivative solution or water was added; 0.1 ml
standardized suspension of 1\1'. pyogenes var. at/rellJ cells was added last.
Each tube was mixed by shaking and placed in a 37°e. watcr bath. Tubes
wcre examined for coagulation every 5 minutes for thc first 30 minutes and
every 10 minutes up to 3 hours. The amount of coagulation was estimated
by the apparent viscosity of the plasma. A numerical value of 4 was assigned
when the tube could be inverted without displacement of the plasma from
the bottom of the tube; a value of 0 was assigned when there was no ap
parent change in viscosity.
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A preliminary study was made on the effect of the addition of erythromy
cin or its derivatives at the time of growth on the formation of coagulase by
IVI. pyogcllcs var. clt/rellS. Tubes containing 5 ml casamino acid medium to
which had been added 12.5, 5 and 1.25 mcg erythromycin, 5 mg desosamine,
5 mg erythralosamine, 5 mg dihydroerythronolide, C~lHH08' and a control
were inoculated with strain no. 3055. A control medium and a medium with
100 mcg erythromycin added were inoculated with strain no. 3066. The co
agulase action of these cultures was noted for the first 60 minutes. The ef
fect of the addition of 100 mcg erythromycin at the time of the coagulase
test on the coagulase activity of strain no. 3055 was also determined.
A second series of tests was carried out using cultures of sensitive ~trains
no. 3055 and no. 3067 and resistant strains no. 3066 and no. 3074 grown in
brain heart infusion alone and resistant strains no. 3066 and no. 3074 grown
in the presence of 100 mcg erythromycin per ml. The coagulase activitj, was
determined for each of these six cultures alone with the addition of 100 mcg
erythromycin at the time of test.
A third series of tests was carried OLlt using cultures of strains no. 3055,
no. 3066, no. 3067 and no 3074 grown in brain heart infusion. At the time
of test, 0, 0.1, 1. 10 and 100 Incg erythromycin were addc:d to ph;ma tubes
with each strain of j"f. pyogenes Vaf. al/rellS to determine the effect on co
agulase activity of erythromycin.
A fourth series of tests was carried out to determi ne the effect of several
degradation products of erythromycin on the coagulase activity of lYf. pyo
genes vae. 4t/ret/S. At the time of test 1000 mcg desosamine, 1000 mcg cia
denose, 100 mcg dihydroerythronolide, 100 mcg erythralosamine, and 1 mcg
erythromycin were added in 0.1 ml distilled water to 0.5 oxalated plasma.
One·tenth ml of suspended cells of M. pyogenes was added to each tube as
well as to a control. Strains no. 3055, no. 3066, no. 3067 and no. 3074 were
used. The time of coagulation of each tube was noted.
The new clinical aid, "Tes.Tape," depends on the activity of glucose
oxidase and horse· radish peroxidase to determine the presence of glucose in
the urine. A 40 mm strip of "Tes-Tape" was wet with 0.05 ml erythromycin
standard solution and allowed to air dry. The antibiotic treated strip and a
control strip were both wet with a 1 per cent glucose solution. Both strips
were dried in the air for 1 minute. The depth of the color of each strip was
compared with the color chart on the tape dispenser.
RESULTS

Screening of Compounds 10 Defermine Rn'erJaL of PolCiltia/ion of AtJ.;oll of
Erythromycin
Compollnds SCfeCiled. Several of the compounds screened showed some
form of activity. Some of these substances reversed the inhibition of the test
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organisms by erythromycin; other potentiated the action of the antibiotic;
still others acted independently of the erythromycin in a toxic effect on the
test organisms or reacted with the media to form opaque areas.
The following compounds reversed the inhibition of test organisms b'y
erythromycin. The diameters of the growth zones on plates seeded with Mi
crococo/J pyogene.r var. at/rem and spores of BC/cililis slIbtilir are here listed:

guanine-HCI, 0.7 per cent, uracil, 1 per cent, and xanthine, 1 per cent.
A number of the compounds which reversed the inhibition of erythromy
cin had a halo-like growth zone. In fact, the onl y one of these reversing com
pounds for which this halo-like effect was not seen was glutathione. Da.ta
giving the diameter of the inner zone of inhibition is given in the paragraph
2, page 79. In seeded plates to which erythromycin had not been added, these
compounds produced zones of inhibition of about the same diameter as the
inner diameter of the halo in plates to which erythromycin had been added.
Oxalic acid reacted with both media to form opaque zones around the
paper disks.
Toxic effects of jWirt·ococC/lS pyogeJles var. twre/ts and spores of Bacillus
JJlbtiliJ produced inhibition zones with diameters as follows:
feSO •. 7H,O, 10 per cent: M. p.. 25 mOl; B. s.. 27 ml<l
D-glucosamine,l per cent:
p., 25 111m; B. S., 13mm
mercaptoethyl amine, 10 per cent: B. s., 50 mlU (no sharp threshold)
thioglycerol, 10 per cent: M. p., 21 mill; B. s., 1(, mm
tetra sodium salt of ethylene diamine tetra acetic acid, 9.4 per cent: iI1. p., 27 mm;

"'1.

1

B.

SO,

34

mIn

FeS0 4 .7H 2 0, 10 per cent, and D-glucosamine, 1 per cent, enhanced the
growth of spores of BClrifftlJ mbliLis with zones 39 mm and 22 mm in di
ameter, respectively.
Hydrogen Ion COllcentration. The hydrogen ion concentration was de
tennined on solutions of all compounds screened except Ca-panthothenate,
pyridoxine, niacin, biotin, desosamine, ZnS0 4 .7H 2 0, TiSO~ and H~BO:>.
The hydrogen ion concentrations of most solutions were found to lie within
the pH range of 5.0 to 7.9. Solutions which had a hyd rogen ion concentration
above or below this range had pH's as follows:
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The neutralized solutions of adenylic acid (4 per cent), ascorbic acid (10
per cent), L-aspartic acid (5 per cent), L·cysteine-HCI (10 per cent), L
glutamic acid (4 per cent), glutathione (2 per cent) and L-histidine· HCl
(5 per cent) gave no evidence of reversing the bacteriostasis of the test or
ganisms, Micro(O((tJs p)'ogenes var. auretfs and Bacillus SlibliLis; caused by
threshold amounts of erythromycin.
L-Cysleine-HC/. Erythromycin which had been treated with L-cysteine
HCl at a pH of 5.2 at 56°C. for 1 hour gave zones of inhibition with both
jHin'ococCtis pyogmeJ var. tlltrnlJ and the spores of Be/cil/lls sub/i/is iden
tical with those obtained from an erythromycin control which had been
treated with no L·cysteine-HC!. After a subsequent 3-day storage in the re
frigerator, potencies were still identical.
Organic and Inorganic A rids. It was found that the inhibition of I\.ficro
coccus pyogenes var. rwre/IJ and the spores 8<lci//;IS sub/iLlS was reversed by
a number of organic and mineral acids. Alanine (2 per cent) and HCl (1 per
cent), glycine (2 per cent) and HCI (1 per lent), HCI (1 per cent), lactic
acid (1 pe.r cent), malic acid (1 per cent), H2S0~ (1 per cent) and tartaric
acid (1 per cent) were effective. In the case of B. sub/ilis these ac.ids in the
aforementioned concentrations caused halo-like zones of growth in plates
containing threshold amounts of the antibiotic. In the case of M. pyogenes the
zone of growth extended to the paper disk on which the acid had been added.
Rui1JaL. It was found that revival of Aficro(o(CIIS pyogenes var. rwreuJ
and spores of BelcilLIIJ JubtiliJ by a threshold amount of erythromycin could
be effected by the compounds which had shown reversal action when added at
the same time as the antibiotic. DL-asparic acid, L-cysteine-HCI and l-histi
dine-HCl brought about the revival of both organisms. Growth could be seen
at 24 hours but was much more evident at 48 hours. Only a small pe.rcentage
of the inhibited organisms were revived. In the case of M. pyogenes va.e.
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atrretl.l most of these appeared to be growing on the surface of the agar. After
becoming aware of the importance of the pH of the compounds screened, it
was found that alanine (2 per cent) and He! (1 per cent), ascorbic acid (4
per cent), l-glutamic acid (2 per cent), HCl (1 per cent) and H~S04 (1
per cent) brought about the revival of B. JIIbtilis. The revival of M. pyogeneJ
var. aure"s was brought about by alanine (2 per cent) and He! (1 per cent),
ascorbic acid (4 per cent), L-glutamic acid (2 per cent), malic acid (1 per
cent) and tartaric acid (1 per cent).
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LClclobcTc;llu.l CcT.le;. In the studies with L. caH:i it was found that
0.2 mcg/ml erythromycin caused an increase in the pH of the blank tubes to
which no Ca-pantothenate had been added after the tubes had heen inoc
ulated and incubated 3 days at 37°e. One mcg/m! of the antibiotic resulted
in a still higher pH (less acid production). The minimal inhibitory level of
erythromycin, i.e., 0.2 mcg/ml erythromycin, 0.02, 0.2 and 2 mcg/ml Ca
pantothenate caused ,1 reversal of thc inhibitory effect and brought about
growth. However, when 1 mcg/ml of the antibiotic was present even 20
mcg/ml of the vitamin caused no appreciable reversal of inhibition (Table
1). When 0.2, 2 or 20 mcg/ml of erythromycin was present, up to 200 fncg/
ml beta-alanine had no growth effect in the presence of 0.2 mcg/nll Ca
pantothenate (Table 2).
SClCl:hal"Omyce.l cerel!iJiae. With the "Gebruder Mayer" strain of S. ce
rev;.litte 10 mcg/m! of erythromycin caused no inhibition. When 100 mcg/ml
of the antibiotic was present, it took 0.02, 0.04 and 0.05 mcg/m! Ca-panto
thenate to bring the growth of the ye,lsl to the level, as measured by the
spectrophotometer, which 0.005, 0.02 and 0.03 mcg/ll11 Ca-pantothenate
attained in the absence 0[ erythromycin (Table 3). Simih1rIy, it required
0.4 and 0.8 mcg/ml beta-alanine in the presence of 100 mcg/ml erythromy
cin to bring about growth equivalent to that of 0.2 an 0.4 mcg/m[ beta
alanine in the absence of erythromycin (Table 4) .
It was necessary to use the level of 100 mcg/ml erythromycin to cause a
reduction of growth of the yeast. It was impractical to use higher concentra
tions of the antibiotic due to its limited solubility.

MicrocoCCll.l pyogeneJ var. auretrs. Strain no. 3055 of M. pyogenes var.
alll'MS was inhibited by 0.5 mcg/ml erythromycin in the absence of either

l'

Ca-pantothenate or beta-alanine; strain no. 3067 was inhibited by 1.0
mcg/ml. With 0.1,1 and 10 mcg/ml Ca-pantothenate added to the medium,
1.0, 0.5 and 0.5 mcg/ml of the antibiotic were required for inhibition of
strain no. 3055 and 1.0, 1.0 and 1.0 mcg/ml of the antibiotic for strain no.
195
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3067. With 10, 100 and 1000 mcg/ml beta-alanine added, 0.5,0.5 and 0.5
mcg/ml erythromycin were required for inhibition of strain no. 3055 and
1.0, 1.0 and 2.0 mcg/ml, for strain no. 3067. Neither Ca-pantothenate or
beta-alanine reversed the inhibitIOn of these strains by erythromycin ap
preciably (Table 5).
DipLocoattJ pnellmoniae. The growth of D. pJZelll770niae was partiaJly in
hibited by 0.005 mcg/ml erythromycin and completely inhibited by 0.01
mcg/mI in the absence of Ca-pantothenate or beta-alanine. The presence of
0.1, 1 and 10 mcg/ml Ca-pantothenate, the organism was inhibited by 0.01
mcg/ml of the antibiotic at all levels. In the presence of 10, 100 and 1000
mcg/mJ beta-alanine, the organism was inhibited by 0.01 mcg/ml erythromy
cin at all levels. Neither growth factor reversed the inhibition of the organ
ism by the antibiotic (Table 6).
Streptococcus pyogener. The growth of S. pyogelles was partially in
hibited by 0.005 mcg/mJ and completely inhibited by 0.01 or 0.02 erythro
mycin in the absence of Ca-pantothenate or beta-alanine. In the presence of
0_1, 1 and 10 mcg/ml Ca-pantothenate, the organism was inhibited at all
levels by 0.02 mcg/ml of the antibiotic. In the presence of 10, 100 and 1000
mcg/ml beta-alanine, the organism was inhibited by 0.01, 0_02 and 0.02
mcg/mI o[ the antibiotic, respectively. Neither Ca-pantothenate nor beta
alanine caused any appreciable reversal of the inhibition of S. PJogel1es by
erythromycin (Table 6).
Corynebtlclerittm diphtheride. The inhibition of C. diphtheriae by erythro
mycin showed no sharp cut-off point. A 0.004 mcg/ml concentration of the
antibiotic permitted maximum growth of the organism; 0.008 mcg/ml,
permitted heavy growth; 0.016 mcg/mL permitted moderate growth; and
0.032 mcg/ml, permitted slight growth. In the presence of 0.1 and 1 mcg/
mI Ca-pantothenate or 10, 100 and 1000 mcg/m\ beta-alanine, the different
concentrations of erythromycin produced the same pattern of inhibition as
in the control which received neither nutrient. When 10 mcg/ml Ca-panto
thenate was used, the pacti<tl inhibition caused by 0.008 and 0.016 mcg/ml
erythromycin appeared to be reversed and that caused by 0.032 mcg/ml of
the antibiotic was not affected (Table 7).
GOIJ' Me/hod. Using the two sensitive strains of i.. . ricrocoafls pJogenes
vae. aurelts, no_ 3055 and no. 3067, in seeded pbtes, there was no evidence
that the resistant strains of AI. pyogenes vae. tlt/relfS, no. 3066 and no_ 3074,
or the resistant organisms ProteuJ -/Julgtlris and Pseudomonas f.1emginosa
produced a metabolite which was capable of diffusing through the <tgar and
reversing the inhibition of erythromycin.

PfodllCtio17 of Pt:mtothenic Arid by Resisl{//]1 Slrt:li/lS of 111icroco(o!S pyo
genes lJar. (/uretJs. Mylase-treated, autoclaved suspensions of resistant and
sensitive strains of iVI. pyogenes were assayed for pantothentic acid content.
The suspension of sensitive strain no. 3055 contained 0.51 mcg/mI panto
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GotJ' 11Jethod. Extracellu!ar Erythro171)'riil<lJe. Using the method of Gots
(4), agar seeded with sensiti ve strains no. 305.5 and no. 3067 of Il-[icrocoe
CIIJ pyogene.. vaL at/reus gave no indication of a diffusible extracellular
erythromycin,lse in either resistant strains no. 3066 and no. 3074 of AI. pyo
ge17er var. auret/J or in the resistant organisms Protein IwlgcrriJ and PJell
domona,r eumginoJa. Using bacteriostatic amounts of the antibiotic in the
agar, there was no growth of the sensitive seeded organisms in the proximity
of rhe resistant organisms.
Breakdoll'll of Erythromycin ill Sollilion by Exlrdcelll!iar Er}'lhlOm ycincjJe.
After incubation the erythromycin containing media surrounding the dialyz
ing tubes which were inoculated with resistant strains no. 3066 and no. 3074
of iHicrofOcms PJogmes var. tlllreus and the antibiotic control still inhibited
the growth of the sensiti ve strain no. 3055 at dilutions up through 1 :64. The
second control. which contained no erythromycin and had been inoculated
vvith sensitive strain no. 3055, produced no substance capable of reducing
growth (Table 8).
SO/11m I Treatmenl of Celll 10 RelecIJe lntra(e!ll/lt/r Erythl'omyr;naJe.
Erythromycin solutions which had bem treated witb the solvent-extracted,
resistant strains of iHicroroul/S pyogmes var. aureus had identical inhibitory
powers. In each case after treatment by defatted cells of strains no. 3066 and
no. 3074, dilutions equivalent to an original concentration of 0.39 meg/Illl
erythromycin inhibited the growth of sensitive strain no. 30.5.5 of M. pyo
genes var. allreus; dilutions e<.)uivalent to an original concentration of 0.10
mcg/ml did not inhibit the growth (Table 9).
Physical Destrt/elioll of Ce!1 J.J'/aLi to Relertse IlltrclcelltJlar Erythromy
cjl1rtJe. Dilutions of erythromycin which had been treated with alumina
ground celts of resistant strains no. 3066 and no. 3074 of MicrocotcttJ pyo
genes var. ourem and the resistant organisms ProteuJ lJUlgal"lJ and Psell
domollrtJ cl(jrt./ginosa and had been subsequently sterilized retained much
erythromycin activity. In all four cases dilutions equivalent to 1.2 mcg/ml
original erythromycin content inhibited growth of the seusitive strain no.
30.5 5 of M. pyogeJles var. allretlSi dilutions equivalent to 0.4 lTIcg/ml original
erythromycin content did not inhibit growth (Table 10).
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In the preliminary test the presence of coagulase was varied when erythro
mycin and several erythromycin degradation compounds had been added to
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the growing organism iHicrOfOUliS pyogenes var. ti/lre1l5. Using str,lin no.
3055, the control with no compound added, cultures grown with 1 mg/ml
desosamine,l mg/ml erythralosamine and 1 mg/ml dihydroerl'thronolide aJl
gave a coagulation value of 4 after 60 minutes. The addition of 100 mcg
erythromycin at the time of the test reduced the coagulation value of no. 3055
to 3 at 100 minutes. Using strain no. 3066, the control gave a coagulation
value of 3 at 60 minutes and the addition of 100 mcg erythromycin at the
time of test reduced the coagulation value to 1 at 60 minutes.
In the SEcond series of tests, using suspensions of M. pyogl!lles var. tltlrellf
which had been standardized by a spectrophotometer, the addition of 100
mcg erythromycin to the mixture of plasma and suspension of organisms at
the time of test increased the time reCjuired for coagulation. The six suspen
sions of the organism coagulated the plasma in pe(iods of time varying from
40 to 80 minutes. When 100 mcg erythromycin was added at the time of the
test, the time required for coagulation was 80 minutes to greater than 3 hours.
The increase in time to bring about coagulation due to the addition of
erythromycin at the time of the test varied from 40 minutes to greater than
140 minutes (Table 11) .
A third test, with all four strains of Ilf. p}ogeneJ var. aliretlS. revealed
that amounts of erythromycin as small as 0.1 mcg increased the time of co
agulation. With all four strains the addition of 1 mcg erythromycin resulted
in still further increases of time required for coagulation. Amounts of
erythromycin in excess of 1 mcg, namely 10 and 100 mcg, did not further
increase time required for coagulation under test conditions but took longer
for coagulation thiln those tubes which received 0 or 0.1 mcg of the anti
biotic (Table 12).

It was found that the addition of 100 mcg/ml erythromycin increased
the growth for resistant strains no. 3066 and no. 3074 of JH. pyogeuer var.
attl'euJ as measured in percentage light transmission from 23 to 20 and 34 to
28, respectively.
In a ftnal test, the effect of several degradation products of erythromycin
on the time required for coagulation was found to vary among the same four
strains of M. pyogenl!s vac. at/rells. The average time required for formation
of a coagulum, finn enough to allow inverting the tube without loss of the
plasma, was 82 minutes. The addition of 1000 mcg desosamine reCjuired on
the average 76 minutes; 1000 mcg cladenose, 80 minutes; 100 mcg eryth
ralosamine, 97 minutes; 100 mcg dihydroerythronolide, 112 minutes; ancl
1 mcg erythromycin, over 160 minutes (Table 13).
"Tes-Tape," the glucose oxidase and horse-radish peroxidase impregnated
paper, was not affected in its reaction to glucose by erythromycin. Tape
previously saturated with erythromycin standard solution reacted to give the
same color upon being wet by glucose solution as a control.
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DiSCUSSION
Screening of CompolllldJ' /0 De/ennine Re·venal of Po/entia/jon of the
Ac/iol1 of El}/hromyt"in

Nearly one hundred com.pounds were screend for effect on the inhibition
of growth of MicfOCOCCJlJ p)'ogeneJ vaI. afiretlS and the spores of Bacillus
slIb/ilis by erythromycin. Solutions of four of these compounds potentiated
the action of the antibiotic and solutions of nine of the compounds reversed
the action. The four compounds which had a potentiating effect were purines
and had been dissolved, using NaOH, with resulting pH's of 9.9 to 10.4.
Solutions of the nine compounds which had shown reversal of the action of
erythromycin were all acidic with pH's ranging from 1.7 to 4.0. Since the
work of Pittenger et a!. (1) and Haight and Finland (2) indicated that an
increase in pH resulted in increased activity of erythromycin, it appeared
that both the potentiating and reversing phenomena resulted from the hydro
gen ion concentration of the solutions screened.
The neutralization of the solutions of screened compounds which showed
activity afforded an opporhmity to determine whether the structure alone
could account for activity. With the four purines, adenine, guanine, uracil
and xanthine, neutralization would result in their precipitation and, there
fore, no useful data could be obtained. Solutions of seven of the nine active
acidic compounds were brought to pH's between 6.2 and 7.0. None of these
solutions retained the ability after neutralization to reverse the action of
erythromycin. As a complementary measure, various other organic and inor
ganic acids were found to reverse the action of.the antibiotic.
Revival, apparently, presents a similar situation. Only solutions of acid
compounds brought about revival and they were for the most part the same
as those which caused reversal. It would appear that the greater proportion
of the Micl'oCOCCJ.l.i p)'ogelleJ vaI. ali/ellS and Belcilflif subtilis cells had been
killed by the "bacteriostatic" concentration of erythromycin. The remaining
resistant bacteria resumed growth afttr the shift to the acid side, by the ad·
dition of the solution to the paper disk, reduced the effectiveness of the
antibiotic to below the bacteriostatic level.
The halo phenomenon was exhibited in both reversal and revival. In
plates seeded with the spores of Bact/Ius sl./.btilis the diameters of the inner
zone of inhibition were larger than those of plates seeded with lvficroi"Ocms
pyogeneJ var. ewre1fJ, The inner zone of inhibition adjacent to the paper disk
appears to be a toxic effect of a low pH. Since BacilltlJ sub/ili.1" requires more
alkaline surroundings it follows that the zone would necessarily be larger.
With an increase in distance from the paper disk one would expect the pH
to rise to a level where the bacteria were not inhibited and at which the con
centration of antibiotic present would be reversed and, finally, at a stiIl
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greater distance the strength of the acid would have been so reduced that
the organisms would again be inhibited by the antibiotic.
It had been suspected that the sulfhydryl radical of cysteine or the closely
related mercaptoethylamine might react with a ketone group in erythromycin
but there appears to be no reaction.
Desosamine, the nitrogen containing sugar which is found in numerous
antibiotics of the erythromycin group, exhibited no activity of any kind.
The activity of erythromycin is due to other characteristics of the molecule.
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hl1lestigatiOlz of the Rel/enaL by Calrif./.1n Pcmtothendte and Beta-Alanine of
the Inhibitory Effa!s of Erythromycm Oil Several Species of Bactel'1a
Very little has been found to support the thesis that Ca-pantothenate and
beta-alanine act as antagonists of erythromycin. Brown and Emerson (4)
used Ca-pantothenate and beta-alanine to reverse the inhibition of Corynebac
te1·i/.t1n diphtheriae by erythromycin. Employing the same medium but using
different strains of the bacterium, Ca-pantothenate and beta-alanine did not
reverse the action of erythromycin. In this study ratios of Ca-pantothenate
and beta-alanine to the antibiotic equalled or smpassed those used by Brown
and Emerson. The data reported here do not confirm their findings, although
other strains were used.
\'{forking with other organisms and V<lrious technics, indications of the
reversal of tbe action of erythromycin by Ca-pantothenate or beta-alanine
were found in two instances. The "Gebriider Mayer" strain of Sarrharomyces
rerevisiae showed reversal of inhibition due to the antibiotic in the presence
of both Ca-pantothenate and beta-alanine. The reversal of erythr,Omycin
was seen at only one inhibitory concentration of the antibiotic since higher
levels were not practical due to its limited solubility. Therefore the nature of
the reversal cannot be determined. Two alternative explanations of the re
sults can be made. Since the yeast requires either Ca-pantothenate or beta
alanine, the antibiotic cannot be inhibiting the growth and di vision by block
ing the production of Ca-pantothenate or beta-alanine. It is possible,
however, that the erythromycin acts by competing with Ca-pantothenate or
beta-alanine for a position in an essential enzyme system. As an alternative,
erythromycin could be interfering with an essential enzyme system which is
distinct from the enzyme system in which Ca-pantothenate and beta-alanine
play an iruportant role. In this situation the addition of a sub-bacteriostatic
amount of erythromycin and the presence of a low amount of Ca-pantothe
nate would interfere with the normal operation of the respective enzyme
systems. While the reduced action of either enzyme system alone would not
prevent growth and reproduction, the reduced action of both enzyme sys
tems would, synergistically, inhibit growth or reproduction. If the reversal
is competitive_ it may be estimated that either 0.02 mcg Ca-pantothenate,or
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1 mcg beta·alanine reverse the action of 100 mcg erythromycin. The activity
coefficients of Ca· pantothenate and beta-alanine would be 5,000 and 100,
respectively. LactobacillNs c,Hei showed no reversal of the action of the anti·
biotic with beta-alanine; but in the presence of the minimal inhibiting con·
centration of erythromycin, the bacterium showed an apparently non·com."
petitive reversal of the inhibition by Ca· pantothenate.
In the other organ isms studied, Ca-pantothenate and beta·alanine did not
re-verse the inhibitory action of erythromycin. The inhibition by erythromy
cin of Diploco((IIJ pneumoniae, j\1irroco((uS p)'ogenes var. al./.rellS! and
SlreptoCO({IIS pyogeneJ was not reversed by Ca·pantothenate at concentra
tions as high as 10 mcg/ml or beta-alanine at concentrations as high as 1000
mcg/m!. The average level of pantothenic acid in human blood was found
by Pearson (47) to be 0.19 mcg/ml. It appears unlikely that vitamin therapy
would increase the pantothenic acid above blood levels at which no reversal
of the action of erythromycin would occur.
If the action of erythromycin were reversed by Ca-pantothenate, resistance
of organisms might be due to synthesis of large amounts of that vitamin.
Amounts of pantothenic acid produced by two highly resistant strains of
AIicTo(O(c/./J pyogenes var. elm'eNS were almost equal to that produced by a
sensitive strain. The enzyme mylase made pantothenic acid in a bound form
available for assay. These data are convincing in showing the lack of any C0111
petitive relationship between erythromycin and pantothenic acid. Since
beta-alanine is a precursor of pantothen ic acid (48), the above data consti
tute indirect evidence that synthesis of beta-alanine is not the means by which
these strains are resistant to the antibiotic.
The evidence that the resistant strains of lYli(l'OCOCCllS p)/ogeneJ var. aurem
and the two organisms, PrOleus [!ltIge/ris and Pseudomonas cterNgilwsc/! do
not produce extracellular erythromycinase, is equally valid as evidence that
they do not produce extracellular metabolites competitive with erythromycin.
With the possible exception of data found using the "Gebriider Mayer"
strain of Sacrhm'omyreJ cerevisiae. all results indicated that neither Ca· pan
tothenate or beta-alanine competitively reversed inhibition caused by erythro
myCI11.

In·lJestigation of tbe Presence of Intracellll/m' etlld Ex/rC/(elllllcrr
Er),thromycillclJe
One mechanism which might account for the resistance of certain strains
and organisms to erythromycin would be the presence of erythromycinase.
The enzyme might be present either in an extracellular form Or in an intra·
cellular form.
Neither of the two resistant iHiao(Occtls pyogelles var. cUlteNJ strains nor
ProtellJ vlIlgariJ nor PsetrdomonclJ aeruginoJC/ reversed the inhibition of the
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two sensitive seed organisms by erythromycin. In addition, resistant strains
of iH. pyogenes var. am'eNS were grown in dialyzing tubes surrounded by
media containing erythromycin. It should be expected that the erythromycin
would diffuse through the cellophane tube to the organisms and be broken
down if erythromycinase were present. Here again there was no indication
of destruction.
It should be noted that if apparent destruction of the antibiotic had oc
curred it would be necessary to determine whether erythromycinase had
destroyed the erythromycin or a competitive metabolite had been produced.
Since no extracellular eryt.hromycinase was found, it can be concluded
that the resistant strains of /\tIicrocOCClIJ pyogem,s var. aureus are truly re
sistant. It had been found previously that some "resistant" organisms pro·
duce an antibiotic destroying enzyme which changes the environment by
reducing the antibiotic concentration below the threshold level so that the
truly sensitive organism can grow. Such is not the case here.
The possibility of an intracellular erythromycinase still remained. The
treatment of cells by fat solvents has been found to render the walls of the
cells permeable enabling molecules as large as penicillin, for example, to
come in contact with enzymes in cells (4). There was no evidence, however,
of erythromycinase in the solvent-treated strains studied. The use of high
freguency sound waves to break down the cell walls was rejected because the
ceJJs of iHicrococclfS pyogel1es var. allreus offer great resistance to this treat
ment. Confirmation by grinding with alundum was chosen since it is ef
fective and yet causes a minimum of denaturation of the protein of the cell.
Apparently there was some absorption of the antibiotic on the alundum and
the contents of the cells; but the amount of erythromycin left free in the
solution after treatment was still many times that necessary to inhibit the
growth of a sensitive strain. Thus, the evidence is strong that intracellular
erythromycinase is not present in the two resistant strains of M. pyogeneJ
var. tltfretiS and in Proteus vulgaris and Pseudomonas aeruginosa.·
No evidence of either extracellular or intracellular erythromycinase was
found in the organisms studied.

The Effect of Erythromycin on the Action of Coagulase and Olhel' Enzymes
Originally it had been suspected that the effectiveness of eryt}uomycin
in vivo in mjce against strains of MiCI'OCOUIIJ pyogenes var. aurefls was due
to an effect on coagulase by erythromycin. This matter was pursued when
Boniece et al. (34) revealed that erythromycin in small amounts reduced the
activjty of coagulase. From the results obtained using four strains of Micro
(OCCUS pyogeneJ var. aureus there is no doubt as to the reduction of the speed
of coagulase activity when small amounts of erythromycin were added at the
time of test. Furthermore, the degradation compounds, c1adenose, desosa·
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Ac/ioll of Coagttlase alld Other Enzymes

that the eftectiveness of erythromycin

mine, dihydroerythronolide, and erythralosamine, had little if any activity
compared with erythromycin. It appears that the property of redUCIng the
activity of coagulase is evanescent as the antibiotic is cleaved IOtO Its COIn
ponent parts. The data concerning dihydroerythronolide and erythralosamlOe
was not statistically significant and it would be worth while to make furthe~
tests of the effect of these compounds on coagulase. The inhibitory action ok
erythromycin cannot be associated with its degradation compounds; desosa
mine, erythralosamine, and dihydroerythronolide.
.
One conclusion is obvious, erythromycin interferes with sensitive strains
of MicroCO((IIS pyogener var. am·ens in at least two ways: it inhibits portions
of the metabolic system which function in the growth and reproduction of
the organism; and it interferes with the action of coagulase. It should be
noted, however, that cOtlgulase was still formed by resIstant stralOs growmg
in the presence of the antibiotic. Erythromycin interferes with the action of
coagulase not with its production,
.
It would appear that with the finding of an antibiotic which protects mice
in vivo against in vitro resistant iHicro(ocO.lJ pyo gmes vaL atlretlS, and the
LKt that the antibiotic reduces coagulase activity, one may have found a
phenomenon of considerable utility. Let it be assumed that erythromycin
counteracts /11. pyogeJle5 var. rl1lfetlS in vivo by reducing the speed ot co
agulase activity. Since the antibiotic does not inhibit the reproduction of the
organism, but inhibits the actioCl of one of its enzymes acting externally, Jt
would appear that there would be little tendency for the development of an
in-vivo-fast strain which would produce a coagulase more reSistant to the ac·
tion of erythromycin. Since this is a most versatile organism, it would appear
more likely that the protection afforded to the animal by the use of the anti
biotic would favor the development of strains which might be resistant to
other Il.ltural host defenses and might kill the host by a method in no way
connected with the coagulase action.
The effect on the speed of coagulase activity may be an in vitro inde>: for
screening drugs and antibiotics for in vivo effectiveness against i~fiCl'oco([tI.r
pyogelles var. LlIII·em. The finding of active substa.nces by thIS 10 vltr~ method
which would be also active in vivo, would, aSIde from the pOSSibility of
clinical usefulness, throw additional light on the manner in which M. pyo
gei/es var. LltlreUf behaves in vivo.
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CONCLUSION
Erythromycin is antibiotic by its interference with the normal funttioning
of one or more enzyme systems in sllsce?tible organisms.
A s<.reening of nearly one hundred compounds, using /l,fjcroco~Cf.lJ pyo
f!.elleJ var. t/l.tl·eus and the spores of Bacilftls sub!ilif; revealed no substances
~:lpable of reversing the inhibition caused by erythromycin. Compounds in
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aCId solution acted to reverse the activity of errthromrtin and (ompound~
in alkaline solution acted to poteMiate its activity; but the basic tause was
the acidity or alkalinity of the solution.
For clinical purposes, the revival of organisms lI1hibited by erythromycin
would appear to be favored by planting into media with as Iowa pH as would
be compatible with the orgaf\ism.
No evidence was found that Ca-pantothenate or beta-alanine reversed
competitively the inhibition by erythrOf\lycin of CorynebacterillllJ diphthe
rial!. Diplocor({fs p"el/II/oniae. uictobdcillllr uuei. MicrococCI!J pJ'ogmec

var. C1llFellS and Strepto(OCWC pyogel/es.
Both Ca-pantothenate and beta·alanine brought about reversal of the
inhibition of S(/uhar(}177Y<'e' cerell/jirle by erythromycin. Owing to solubility
limitations it was not possible to use larger amounts of the antibiotic and
determine the presence of a competitive reversal of the type exhibited by
p-aminobenzoic "cid and the sulfa drugs over large variations of concentra
tion.
No evideme was found of the synthesis of a metabolite comf)etitive with
erythromycin by re,istant organisms. Resistant straillS of i'vl;ao(o£'('11.I pyo
gt1zes var. allreliS synthesized the same amount of pantothenic atid as <I sen
sitive strain. Gats' test demonstrated that resistant strains of ;H. pyogenl!'
\ar. tiliretl\' Protem !'lilgrll'lf, :lnd P1emlomolltJs aertlglflOf(/ synthesized no
extracellular metabolite capable of reversing the action- of erythromycin.
Neither eJ'tracellular nor intracellular erythromycin,lse was found in i\'(/
l1'OCO(OIS pyogeJles var. ,.lIIre"f. P"otellJ IllIlgar;J. or Pll!lIdomo!l(/s rtemgillosa.
Neither solvent treatment nor mechanical rupcuring of cells released such an
cnzyme.
Desosamlne, " structure common to numcrous members of the erythromy
cin 'lntibjotic group, has no effect on the action of erythromyci n and Ius no
bacteriostatic effect on iHicroco(CIIS pyogeneJ var. CinreltS or on the spores of
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The finding of Boniece et al. (34) that erythromycin reduced the activity
of the coagulase of il,firrocou/lJ pyogelll!r var. tltlreus was confirmed. Desosa
mine and c1adcnose, degradatjon products of erythromycin, did not reduce
the activity of coagulase. It is suggested that additional work should be done
to determine whether the reduction of activity of coagulnse by dihydro
erythronolide and erythralos'lmine is significant. None of the four degrada.
tion products of erythromycin tested had an effect on coagulase whith
approached that of the antibiotic.
Erythromycin had no effect on the emymes glucose oxidase and horse
radish peroxidase.
It is suggested that in view of erythromycin's reduction of the activity of
coagulase, there may be little tendency for "in vivo resistant" strains of A(i
rrorocC!/j pyogmeJ var. d1l1'etlJ to develop. The coagulase activity test is
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recommended ciS an in virro method for the testing of drugs for their in vivo
effectiveness against Ai. pyogel7es var. clt/rellS.
The inactivity of variollS metabolites on the action oi erythromycin, the
inability of Ca-pantothenate and beta-alanine to reverse the inhibition of.
nU!;leroUS organisms by the antibiotic, and the apparent absence of erythro
mycinase, lead to the conjecture that the 1110st fruitful areas of study of the
mode of action would be: 1. the investigation of the effect of erythromycin
on the various enzyme systems in the bacterial cell; 2. the comparison of th?
enzyme systems of sensitive and resistant strains of the same organism.
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3.2

024
.1l6
.216
.242
.276
.300

.009
.135
.211
.266
.290
.294

.004

.003
054
.126

.195
.264
.274
.296

.224
.276
.282

TABLE 5

LE 3
Effen of Beta-Alanine and Calcium Pantothenate on the Growth* of M ;c)"OCO""'5
P)'lif!.tI1fJ var. allrellS, Strains no. 3055 and 3067.

hen ate and Erythromycin
bruder !\"fuyer" Strain

erythromycin mcg/ml

ceJ fC'J'e'rhi:le

Str.in no. 3055

Strain nO. 3067

in mq:/ml
10

lOa

Calcium
Pao£othen:ue
meg-/ml

adiogs in OPtical densio.. )

.oL6
.073

.095
.116
.122
.128
.136

.015
.072
.080
.122
.126
.134
.137

.0lD
.044

.055
.078
.102
.123
.129

0.0
O.L
1.0
10.0

0.0

0.1

0.2

0.5

l.0

<i
4
4

4
<I
4
4

4
<i
4
4

0

0

0
0
0
0

4

4

4

4

.-I
4

4

"

4

4

<I

4

0
0
0
0

0
0
0
0

4

<i
0

0·0

0.1

0.2

0.5

l.0

4
4

0
0

4

.-I

4

if

4

4

4

4
4

0
0
0

4

0

()

<I

<I

4
4

4
4

4

4

4
4
4
4

0
0
0
0

0
0
0

a

Beta
Alanine
mcg/ml

0
10
100
1000

a

Growth was determined bv visuaL estimate of lurbidity. Very heavy growth was given a
vahle of 4; hea\'Y growlh~ 3; moderate growth, 2; slight growth. 1; and no growth. 0,

TABLE G
EFfecr of Bera·AJanine and Calcium Pancorhenate on d,e Grow,h* of D,plr"wm,
pnemno"iae Park I and StreploCQcCII.' pyn¥"Jld C203
D.

S.

py()gelle~

.005

.010

!U]eI(J!lfj"iat

Gem
nn

erylhromycin mcgjmL

.000

.005

.010

.020

.040

.000

.020

.040

Ca-PaOlo.
theoale
mcg/ml

Dilu
from
Ing I

0.0
0.1
1.0
10.0

4

"4

2
2
2

4

2

4
4
4
4

2

0
0
0
0

0
0
0
0

0
0
0
0

4
4
4
4

0
0
0
0

0
0
0
0

0
0
0
0

2

2

2
2

2

2

2

4

2

4.
4.

2
2
2

0
0

2

0
0
0
0

0
0
0
0

0
0
0
0

0
0
0
0

Bera·
Alanine
m,g/ml

• Gr<

0
]0
100
1000

2

2

2

4

2

value

2
Growth was determjned by visual es(im,\Ie of turbidj(y. Very heavy growth was given a
vaJue of 4; heavy growth) 3; moderale gcowth, 2; slight growlh, l ~ and no growtb, O.

TABLE 7
Effec' of Beca-Alanine and Calcium Pancothenate on rhe Growrh* of Corynelutcf.eri"",

diphlheriae
SIr.in

x- ~ 66

Strain Toronto

ery,bromydo meg/ml
.000

.004

.008

4
4
4
4

4

3
3
3

.016

.032

.016

.000

.004

.008

4
4
4

4
4
4
4

3

2

3
3

2
2

4

4

.032

Ca-PaOlo

EQuiv
Prese

rhenare

meg/mJ

0.0
0.1
1.0
10.0

<1

4
4

4

2

2
2
4

"

Be,.Alaoioe
meg/ml

0
10
100
1000

, Gte
value

4
4
4
4

4.
4
4
4

3

2

1

3

2
2

1
1
1

4
4.
4
4

4
4
4
4

3
3
3
3

2
2

2
2
2
3
.. Growth was dere(mined by ,'isual esrima[e of turbidity. Veo' beav.v growth was given a
value of 4; heavy grow,b. 3; moderate grow,h, 2; slight growth, l; and no growth, O.

3
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TABLE 8
ammhenme on rhe Growrh * of Dipl{)<."Ocof'
S"·ep/[)(&WI.r pyogmn C203
5. P)'Ogenei

.040

.000

.005

.010

.OZO

Gwwrh * of M IcrOCOLW'< p)'Ogme.< var. attrtitJ in rbe Presence of Dllurions of Eryrhromy.
Cln Treared by Con mer IVlrh Dialyzing Tubes Seeded wirh ReSlsranr Smllns of M.
jJ)'oge1UJ val. ,lIIreu.l
Not Inoculaced

.040

Dilution of medium
from ourside of d'alyz
ing rubes

o

4

2

o
o
o

4

2

4

2

4

2

2
2
2
2

0
0
0
0

o
o

1

1

o
o

1
1
1
1
~

0

:j

0
0
0

4
4
4

2
2
2

0
0

2

2

2

0
0
0
0

0
0
0
0

2
4

8
16
32

64

SLraill
5rrain
Strain
no. 3066
no.3074
no. 3055
erylhromycin mcg/ml (originill COrlCenrc31jon)

100

100

100

0

0
0
0
0
0
0

0
0

0
0
0
0
0
0

4
4
4

0
0

0
0

Growth was determined by visual csdmare of turbidity.

4
4
4

Vee}' heavy growth was ghen

i\

value of 4; heavy growlb, 3; moderare growrh. 2; slight grow(h. 1; and no growth, O.

e of turbidity.
• 2; slj~ht

Ver)' heavy growth was gi"en a
growrh, 1; and no grow lb. O.

LE 7
odlenate on rhe Growrh * of Coryml}(lCfaillm
tho'i"f

Growrh* of MicrocoutiS pyogmcs val. a"reuJ in rhe Presence of Dilutions of Eryrhromy·
cin Treared by Solvenr·Exrracred Resisram Strains of M. pyogene.' val. aureltJ

Strain Toronto
ythrom)"cin ntcgjrnl

.032

.000

4
4
4
.~

.004

.008

TABLE 9

.016

.032

4
4

3

2

1

3

4
4

3

2
2

4

4

1
1
1

Equivalenl of ErYlhromycin Originally
PreseQ( afler Dilurion meg/ml

a

Control

100.00

0

2~.OO

0

6.25
1.56
0.39
O.lO
0.00

0
0

Strain
no. 3066

Strain
no. 3074

0
0
0
0
0
4

0
0

0

4
4

Growch was determined by visual estimate of curbidjty.

4
Very

be~n'Y

()

0
0

4
4
growth was given a

value of 4; heaYy growth, ~; moderate growth. 2; slight growth, 1; and no growrh, O.

1
1
1
1

'i
4
4
4

of lurbidjt),.

4
4
4
4

3
3
3
3

2
2
2
2

Yen' heav,:, growth was given a

.2; slight growth, 1; and no growth~ O.
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TABLE 10
Growth" of ilyficrococClis p)'ogenes var. allTeIl! in the Presence of Dilurions of Eryrhro
mycin Treated by rhe Ruprured cells of Four Banerjal Srrains

Effecr of

EQuivaleot of Ery[hromy.
cin OdginaHy Presenr
after Dilution

Strain no

mcgJml

11.0
3.7
1.2

0.4
0.13
0.0

i\(i,cro(:oc:clls pyogeuesvar. 411relt$

Slcain
no. 3066

Stcain
no. 3074

0
0
0
4

0

ProteffJ
IlIflgariJ

0
0
0

0
4
4
4

4

aerllginord

Erythron
of test n

0

4

P5eudomOfldJ

0
0
0
4
4

4

4
4

'(

" Growtb was determined by a visual estimate of turbidity. Very heavy growth was given a
value or 4: hea\'y 8ro"CV[h, 3; moderale growth) 2; sligh( growth, 1; and nO growth. O.

TABLE 11

E

Effecr of Eryrhromycin on rhe Coagulation of Plasma by
,u,rellS
Straio no.
Erythromycin dueing gcowlh

3055

o

,\1.j'TOCOCClIJ p)'ogene.<

var.
Strain n(

3066

3066

3067

3074

3074

o

lOa

o

o

lOO

mcg!ml

Compo
at (In

None,

Eryrbromycin added at
rime of lesr meg/ml

I

Desosa
meg.
minutes required for coagulation

0

'(0

40

40

50

80

50

100

80

over

130

140

180

180

180

Cladenl
meg
Eryrhta

100

J

Dihydr
Increase in time due ro
erythromycin

40

over

140

210

90

90

100

130

100

I

Eryrhrc
I me

TABLE 12

ABLE 10
reUJ in the Presence of Dilutions of Eryrhro·
ured cells of Four Bacterial Strains
ProJeus
v"lgaris

4Nrtlls

P ..eltdonroJuJJ

Effecr of Different Concenrrarions of Eryrhromycin on rhe Coagularion of Plasma by
Mic1'OfOCCII.r

S(cain

Eryrhrornycin added at rime
of resr mcg/ml

0
0
4
4
4

3066

3055

00.

aurellj

3074

3067

aerJlgi"05Q

SCnlio
no. 3074
()

p)'ogt'lZe.r var.

0
0
0

0
0
0

4

4

4
4

4

0
0.1

4

minures required for coagularion

30

40

40

)0

40

60

80

70

70

130

150

over 180

10

70

130

100

130

100

70

90

90

100

'mare of [urbidiry. Very heayy growlh was gi\len a
""h, 2; sligh' grow,h, I; and 00 grow'h. O.

TABLE 13
ABLE 11

Effect of Degradarion Products of Erythrornycin on the Coagularion of
Plasma by Mi"rocoeem pyogenes vaL al/reltJ

ularion of Pbsma by MitrocorCIIJ p)'ogemJ vaL
Sc,Calll 00.

tlllrPIIJ

3066

o

3066
100

3067

3074

o

o

3074
100

s required for coagularion

40
over
180
over

140

210

40
130

90

)0
140

90

80
L80

100

)0
L80

130

3066

3055

Compound added
ar rime of test.

3074

3067

minutes required for coagulation

None, control ...

30

70

130

100

Desosamine. 1000
mcg.

40

60

100

100

CJadenose, 1000
mcg

)0

70

100

100

Erythralosamine,
100 mcg.

60

70

130

130

Dihydroeryrhronolide
100 mcg.

60

130

130

130

100

over 180

over L80

Over 180

Erythromycin,
1 mcg.
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